Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974391

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974389

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974388

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974387

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974382

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974381

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974377

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974376

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974375

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974373

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Successive Delivery Of Drugs Used In The Treatment Of Pulmonary Fibrosis And Lung Cancer Severe Asthma Multidrug Resistant Tuberculosis Atopic Dermatitis And Chronic Spontaneous Urticaria Available Under Drug Programs To The Provincial Complex Of

Deadline: 20 Aug 2026

Poland

Ref. No.: 27974372

EMD:Ref Document

Bid Value: Ref Document

79 Days Left

Open House Biologics Discount Agreements 2026 17 Interferon Beta 1B Finished Medicinal Product Betaferon R

Deadline: 30 Jun 2028

Germany

Ref. No.: 27974328

EMD:Ref Document

Bid Value: Ref Document

759 Days Left

Electronic Auction Acquisition Of Immunotherapy Extract

Deadline: 09 Jun 2026

Brazil

Ref. No.: 27974324

EMD:Ref Document

Bid Value: Ref Document

7 Days Left

Conclusion Not Excluding Drug Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Lanthanum Iii Carbonate In The Dosage Form Chewable Tablets

Deadline: 31 Jul 2028

Germany

Ref. No.: 27974099

EMD:Ref Document

Bid Value: Ref Document

790 Days Left

Electronic Auction Establishment Of A Price Registration System For Future And Eventual Acquisition Of Medicines

Deadline: 10 Jun 2026

Brazil

Ref. No.: 27974076

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!